Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Dec 19, 2023

BUY
$98.98 - $115.74 $3.19 Million - $3.74 Million
32,279 Added 29.8%
140,586 $16.3 Million
Q3 2023

Nov 15, 2023

BUY
$98.98 - $115.74 $3.19 Million - $3.74 Million
32,279 Added 29.8%
140,586 $16.3 Million
Q2 2023

Dec 19, 2023

SELL
$96.34 - $112.38 $361,371 - $421,537
-3,751 Reduced 3.35%
108,307 $11.1 Million
Q2 2023

Aug 15, 2023

SELL
$96.34 - $112.38 $361,371 - $421,537
-3,751 Reduced 3.35%
108,307 $11.1 Million
Q1 2023

Dec 19, 2023

SELL
$107.32 - $113.5 $467,807 - $494,746
-4,359 Reduced 3.74%
112,058 $12.2 Million
Q1 2023

May 15, 2023

SELL
$107.32 - $113.5 $467,807 - $494,746
-4,359 Reduced 3.74%
112,058 $12.2 Million
Q4 2022

Dec 19, 2023

SELL
$62.39 - $113.8 $1.51 Million - $2.75 Million
-24,169 Reduced 17.19%
116,417 $13.2 Million
Q4 2022

Feb 15, 2023

SELL
$62.39 - $113.8 $64,261 - $117,214
-1,030 Reduced 0.88%
116,417 $13.2 Million
Q3 2022

Nov 15, 2022

SELL
$58.92 - $84.67 $2.06 Million - $2.97 Million
-35,031 Reduced 22.97%
117,447 $7.27 Million
Q2 2022

Aug 15, 2022

SELL
$79.4 - $116.36 $3.18 Million - $4.66 Million
-40,050 Reduced 20.8%
152,478 $12.2 Million
Q1 2022

May 16, 2022

BUY
$86.42 - $109.81 $3.77 Million - $4.78 Million
43,572 Added 29.25%
192,528 $20.3 Million
Q4 2021

Feb 15, 2022

BUY
$98.56 - $119.91 $186,968 - $227,469
1,897 Added 1.29%
148,956 $16.1 Million
Q3 2021

Nov 15, 2021

BUY
$91.91 - $110.37 $1.06 Million - $1.28 Million
11,570 Added 8.54%
147,059 $16.1 Million
Q2 2021

Aug 16, 2021

BUY
$86.24 - $95.92 $1.06 Million - $1.18 Million
12,336 Added 10.02%
135,489 $12.7 Million
Q1 2021

May 14, 2021

BUY
$71.83 - $95.48 $363,603 - $483,319
5,062 Added 4.29%
123,153 $11.3 Million
Q4 2020

Feb 12, 2021

BUY
$67.0 - $84.39 $7.91 Million - $9.97 Million
118,091 New
118,091 $8.64 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.